Inactive Instrument

News Dipexium Pharmaceuticals Inc Nasdaq

Stocks

US25456J1043

All News

7d3b34eed7845d880b54c1d7011c2.vIZD629dfe3Ei9Xbhm0lv-hgFOIG31Nhv506Vhi1wik.y_YNkQRpKa6D2OCe9Shv8dEJfLdIrDoRzsVpPHD2gWLe4TWMBwI2gPH54Q

29/09/23	PLx Pharma Winddown Corp. Went Out of Business	CI
14/09/23	First Amended Combined Liquidation Plan and Disclosure Statement Approved for PLx Pharma Winddown Corp.	CI
28/08/23	First Motion for Exclusivity Period Extension Approved For PLx Pharma Winddown Corp.	CI
10/08/23	First Motion for Exclusivity Period Extension Filed by PLx Pharma Winddown Corp.	CI
28/07/23	First Amended Disclosure Statement and Related Plan on Interim Basis Approved for PLx Pharma Winddown Corp.	CI
26/07/23	First Amended Combined Liquidation Plan and Disclosure Statement Filed by PLx Pharma Winddown Corp.	CI
08/07/23	Plx Pharma Winddown Corp. Announces Resignation of Natasha Giordano as Chief Executive Officer	CI
08/07/23	Plx Pharma Winddown Corp. Announces Resignation of Rita Oâ€™Connor as Chief Financial Officer	CI
08/07/23	Plx Pharma Winddown Corp. Announces Executive Changes	CI
07/07/23	Combined Disclousre Statement and Liquidation Plan Filed by PLx Pharma Winddown Corp.	CI
27/05/23	PLx Pharma : Material Agreement - Form 8-K	PU
25/05/23	Motion for Asset Sale Approved for PLx Pharma Winddown Corp.	CI
19/05/23	Notice for Auction Cancellation Filed PLx Pharma Winddown Corp.	CI
10/05/23	Bidding Procedure Approved for PLx Pharma Inc.	CI
17/04/23	PLx Pharma Inc.(OTCPK:PLXP.Q) dropped from S&P TMI Index	CI
17/04/23	PLx Pharma Inc.(OTCPK:PLXP) dropped from S&P TMI Index	CI
14/04/23	Motion for Joint Administration Approved for PLx Pharma Inc.	CI
14/04/23	PLx Pharma : Bankruptcy - Form 8-K	PU
14/04/23	PLX PHARMA INC. : Bankruptcy or Receivership, Financial Statements and Exhibits (form 8-K)	AQ
13/04/23	Motion for Asset Sale Filed by PLx Pharma Inc.	CI
13/04/23	Motion for Joint Administration Filed by PLx Pharma Inc.	CI
13/04/23	PLx Pharma Inc. Filed for Bankruptcy	CI
13/04/23	PLx Pharma Signs Stalking Horse Deal to Sell Assets to Greenwood Brands; Shares Jump After Hours	MT
13/04/23	PLX PHARMA INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
13/04/23	PLx Pharma Inc. Enters into a Stalking Horse Asset Purchase Agreement to Sell VAZALORE® and Substantially All of its Assets	AQ